Nexus Pharmaceuticals, Inc. Announces Approval of Emerphed™ (ephedrine sulfate) Injection, the First and Only FDA-approved, Ready-to-Use Ephedrine Injection (50 mg/10 mL vial)

An experimental compound prevents the virus that causes COVID-19 from entering human airway cells, a new study finds.

European Commission Approves Reblozyl (luspatercept) for the Treatment of Transfusion-Dependent Anemia in Adult Patients with Myelodysplastic Syndromes or Beta Thalassemia

Wadhwani Foundation Announces $1 Million In Grants To Immediately Help Indian Families Impacted By Covid-19. Donations to 10 charities and organizations will provide medical and financial assistance to patients and families to help reduce the devastating impact and slow COVID-19 spread.